Privacy Policy

Login

Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av MFN som distributionsmotor?

Läs mer!

14:10:49 Europe / Stockholm

Svenska | English

Penser Access by Carnegie

Prenumeration

Interview with Ascelia Pharma - Carnegie Investment Bank - Feb 21th 2024

2024-02-21 16:20:00

We have interviewed the CEO and Vice CEO of Ascelia Pharma to provide an update on the company's status. Topline data for the company's lead project, Orviglance, is expected in May.

Find the interview on Penser Play: https://youtu.be/HIue6f9vhDU?si=I05Auv-199WNGEFp
This is a press release from Carnegie Investment Bank. Read more here: https://epaccess.penser.se/

Penser Access by Carnegie

Prenumeration

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden